The rise in the number of insect-borne diseases is driving the growth of the insect repellent market in Europe. In order to protect themselves from diseases caused by mosquitoes or ticks, consumers prefer different insect repellent products such as apparels, oils and creams, and stickers and patches among others. According to the European Centre for Disease Prevention and Control, the changing climatic conditions would increase the habitation of tiger mosquitoes in the Northern part of Europe on account of warmer and wetter weather conditions. All these factors are likely to increase health awareness among European consumers, which in turn is expected to drive the usage of insect repellent products in Italy, France, Spain and other European countries during the forecast period.
In addition, insect repellents are marketed through strong distribution channels such as online stores, supermarkets, and convenience stores. Increasing availability of these products in stores and supermarkets are also promoting the growth of the insect repellent market in Europe. Moreover, manufacturers also sell insect repellent products through internet retailing. The collection, variety, discount, and price range of products available with internet retailers is diverse leading to increasing popularity of the channel. Many companies are entering into joint venture agreements with different online stores in order to market these products through their websites.
Key manufacturers operating in the insect repellent market are continuously focused on developing safe and innovative insect repellents. These products provide protection from critical insect-borne diseases such as malaria, dengue, Lyme disease, and yellow fever among others. With advancement in technology, insect repellents are being made from natural products such as lemongrass, citronella oil, and eucalyptus oil which produce less smoke and are comparatively safer.
However, stringent government regulations prevailing in Europe hinder the growth of the insect repellent market. Various organizations such as the European Environmental Agency and the European Medicines Agency have implemented different safety standards to conclude whether an insect repellent is harmless enough for its intended use, thereby maintaining consumer safety.
To Get Free Sample Copy Of Europe Insect Repellent Market
Increasing demand for new and innovative insect repellent products containing natural ingredients is likely to create significant opportunity for growth of the European insect repellant market in the future.
This market research study analyzes the insect repellent market in Europe and provides estimates in terms of revenue (USD Million) from 2014 to 2023. It recognizes the drivers and restraints affecting the industry and analyzes their impact over the forecast period from 2015 to 2023. Moreover, it identifies the significant opportunities for market growth in the years to come.
The report segments the market based on product type which includes body-worn insect repellent and non body-worn insect repellent. The body-worn insect repellent segment is segmented into oils and cream, apparels, stickers and patches, and aerosols. The oils and cream segment is further divided into synthetic and plant based insect repellents. Moreover, the aerosol segment is classified into Deet and Non Deet. The non body-worn insect repellent segment is subdivided into coils, mats and sheets, aerosols and liquid vaporizers. The aerosol segment is further bifurcated into Deet and Non Deet. By countries, the insect repellent market in Europe is subdivided into Germany, U.K. France, Italy, Spain, Belgium, Switzerland, Netherlands, Denmark, Norway, Sweden, Finland, Iceland, and rest of Europe.
The report provides company market share analysis of the various industry participants. Key players have also been profiled on the basis of company overview, financial overview, business strategies and key developments. Major market participants profiled in this report include Avon Products Inc. (U.S.), S.C. Johnson & Son, Inc. (U.S.), 3M Corporation (U.S.), E.I. DuPont de Nemours and Company (U.S.), BASF S.E (Germany) and Omega Pharma (Belgium).